COVID-19 India Updates | Covaxin approved for children | Vaccines for teenagers




China released the 2022 NDRL list, Chinese pharma benefited from the list


WHO granted EUL to Covaxin; acclaims easy storage requirement


Novartis and BeiGene collaboration strengthens the Swiss drugmaker's oncology portfolio

Bayer submitted vericiguat for market authorization in China


Bayer’s Xofigo received approval for prostate cancer in China


Merck’s Keytruda received one more indication and dosage form approval in Japan


AZ received one more approval in Japan, received approval of Imfinzi for SCLC


JAPAN HEALTHCARE SYSTEM
China’s National Medicinal Products Administration approved Gilead’s Truvada
Eisai's Dayvigo was approved in Japan and Hong Kong for insomnia
Merck’s Keytruda approved in China for esophageal squamous cell carcinoma
GSK and Clover Biopharmaceuticals begins COVID-19 vaccine Phase 1 clinical trial


May witnessed the approval of Pfizer’s Talzenna, Nyprax’s Tukysa, Drug Houses’ Ajovy in Singapore
Gilead announced the positive Phase 3 trial of remdesivir in COVID-19 patients